Grant: Collaborative Health Research Projects
McGill University
$167,150.00
Novel Delivery System for High Dose Rate Intensity Modulated Brachytherapy with Yb-169 as a Radiation Source
EF 2019-20
Résumé
Radiotherapy is an effective and safe treatment for cancer. Approximately 50% of cancerpatients benefit from this treatment, that is, close to 100,000 Canadians with cancer eachyear. Brachytherapy, is a form of radiotherapy where radioactive sources are placed inside ornear the tumours using thin, hollow tubes (catheters) implanted for a short period of time,giving a high radiation dose to the tumour while maintaining a low dose to surrounding healthy tissues. However, dose distribution in conventional brachytherapy is identical in all directions resulting in dose spillage to radiation sensitivehealthy tissues. This proposal aims to develop a novel radiation delivery system that willmanipulate the radiation dose to conform to the shape of a tumour by incorporating radiationshields inside the implanted hollow tubes, i.e. the delivery system will modulate the intensityof the emitted radiation from the brachytherapy source. The shields can rotate during thetreatment, direct the radiation towards the tumour and away from healthy tissues. Developing and making intensitymodulated brachytherapy clinically available, will significantly improve the potential ofbrachytherapy with reduced toxicity will increase the cure rates and improve the quality of lifefor Canadians with prostate, breast, cervical, uterine, vaginal, vulvar, head & neck andoesophageal cancers. In addition, this proposal will offer undergraduate and graduate studentto work in a multidisciplinary environment with radiation oncology, radiation physics, biology,computing and engineering.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
523394-2018
Name nom
AbbasinejadEnger, Shirin
Department département
Medical Physics Unit
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
167150
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Novel Delivery System for High Dose Rate Intensity Modulated Brachytherapy with Yb-169 as a Radiation Source
Keyword
NSERC
Application summary
Radiotherapy is an effective and safe treatment for cancer. Approximately 50% of cancerpatients benefit from this treatment, that is, close to 100,000 Canadians with cancer eachyear. Brachytherapy, is a form of radiotherapy where radioactive sources are placed inside ornear the tumours using thin, hollow tubes (catheters) implanted for a short period of time,giving a high radiation dose to the tumour while maintaining a low dose to surrounding healthy tissues. However, dose distribution in conventional brachytherapy is identical in all directions resulting in dose spillage to radiation sensitivehealthy tissues. This proposal aims to develop a novel radiation delivery system that willmanipulate the radiation dose to conform to the shape of a tumour by incorporating radiationshields inside the implanted hollow tubes, i.e. the delivery system will modulate the intensityof the emitted radiation from the brachytherapy source. The shields can rotate during thetreatment, direct the radiation towards the tumour and away from healthy tissues. Developing and making intensitymodulated brachytherapy clinically available, will significantly improve the potential ofbrachytherapy with reduced toxicity will increase the cure rates and improve the quality of lifefor Canadians with prostate, breast, cervical, uterine, vaginal, vulvar, head & neck andoesophageal cancers. In addition, this proposal will offer undergraduate and graduate studentto work in a multidisciplinary environment with radiation oncology, radiation physics, biology,computing and engineering.